Nyxoah SA
XBRU:NYXH

Watchlist Manager
Nyxoah SA Logo
Nyxoah SA
XBRU:NYXH
Watchlist
Price: 8.04 EUR 1.77% Market Closed
Market Cap: 276.3m EUR
Have any thoughts about
Nyxoah SA?
Write Note

Nyxoah SA
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nyxoah SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nyxoah SA
XBRU:NYXH
Accrued Liabilities
€4.8m
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Biocartis Group NV
XBRU:BCART
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Accrued Liabilities
€33.1m
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Accrued Liabilities
€2.2m
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
N/A
No Stocks Found

Nyxoah SA
Glance View

Market Cap
276.5m EUR
Industry
Health Care

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 72 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

NYXH Intrinsic Value
3.52 EUR
Overvaluation 56%
Intrinsic Value
Price

See Also

What is Nyxoah SA's Accrued Liabilities?
Accrued Liabilities
4.8m EUR

Based on the financial report for Dec 31, 2023, Nyxoah SA's Accrued Liabilities amounts to 4.8m EUR.

What is Nyxoah SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
42%

Over the last year, the Accrued Liabilities growth was -5%. The average annual Accrued Liabilities growth rates for Nyxoah SA have been 34% over the past three years , 42% over the past five years .

Back to Top